Anti-Cdk4 antibody [EPR4513-54-3]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(6 Publications)
Rabbit Recombinant Monoclonal CDK4 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 6 publications.
View Alternative Names
Cyclin-dependent kinase 4, Cell division protein kinase 4, PSK-J3, CDK4
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody [EPR4513-54-3] (AB108355)
Immunofluorescence staining of MCF7 cells with purified ab108355 at a working dilution of 1/100 counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077) used at a dilution of 1/1000. ab7291 a mouse anti-tubulin antibody (1/1000) was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse 1/1000) shown in the top right hand panel. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1 purified ab108355 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2 ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody [EPR4513-54-3] (AB108355)
ab108355 staining Cdk4 in wild-type HAP1 cells (top panel) and Cdk4 knockout HAP1 cells (bottom panel). The cells were fixed with 100% methanol (5min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab108355 at 1/400 dilution and ab7291 at 1μg/ml concentration overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to Mouse IgG (Alexa Fluor® 594) (ab150120) (shown in pseudo colour red). Nuclear DNA was labelled in blue with DAPI.
- WB
Lab
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (AB108355)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (ab108355) at 1/5000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
Ramos cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- WB
Unknown
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (AB108355)
Lanes 1, 3 and 5 : Wild-type HAP1 cell lysate (20 μg)
Lanes 2, 4 and 6 : CDK4 knockout HAP1 cell lysate (20 μg)
Lanes 1 and 2 : Green signal from target - ab108355 observed at 34 kDa
Lanes 3 and 4 : Red signal from loading control - ab8226 observed at 42 kDa
Lanes 5 and 6 : Merged (red and green) signal
ab108355 was shown to specifically react with CDK4 when CDK4 knockout samples were used. Wild-type and CDK4 knockout samples were subjected to SDS-PAGE. ab108355 and ab8226 (loading control to beta actin) were both diluted at 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (ab108355)
Predicted band size: 162 kDa,34 kDa,41 kDa,43 kDa,51 kDa,53 kDa,55 kDa,68 kDa,84 kDa,89 kDa,93 kDa
Observed band size: 62 kDa,69 kDa,89 kDa
false
- WB
AbReview45216****
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (AB108355)
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-54-3] (ab108355) at 1/1000 dilution
Lane 1:
Human osteosarcoma cells - control, non-targeting siRNA at 20 µg
Lane 2:
Human osteosarcoma cells - siRNA for CDK4 at 20 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG polyclonal at 1/2000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
true
Exposure time: 5s
This image is courtesy of an Abreview submitted by Sonia Rocha
Related conjugates and formulations (1)
-
Anti-Cdk4 antibody [EPR4513-54-3] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdk4 plays a fundamental role in cell cycle regulation by forming a complex with D-type cyclins. Together they phosphorylate the retinoblastoma protein (Rb) resulting in the release of E2F transcription factors which promote the expression of genes necessary for DNA replication. The Cdk4/cyclin D complex regulates the cell's commitment to enter S phase and continue cell division. This regulation is key for normal cell proliferation and tissue homeostasis. Cdk4 activity is strictly controlled by INK4 family members acting as inhibitors and adding an extra regulation layer.
Pathways
Cdk4 is an integral part of important signaling pathways like the cell cycle and PI3K/AKT pathways. In the cell cycle pathway Cdk4 relays signals downstream that drive the transition from the G1 to S phase through its interaction with cyclin D and Rb. In the PI3K/AKT pathway signaling can influence cyclin D expression indirectly affecting Cdk4 activity. Proteins such as Cdk6 closely relate to Cdk4 and often compensate or partner with Cdk4 in these pathways to maintain proper cell cycle progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Endocrine journal 69:1117-1129 PubMed35545536
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34476505
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 47: PubMed33955505
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 380:198-204 PubMed31004581
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 234:15420-15428 PubMed30701534
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:8216 PubMed29844447
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com